Radioimmunotherapy with 90Y-Zevalin in mantle cell lymphoma patients.

被引：0
|
作者：
Sowa-Staszczak, A.
Hubalewska-Dydejczyk, A.
Jurczak, W.
Huszno, B.
Giza, A.
Wegrzyn, J.
Skotnicki, A.
机构：
[1] Jagiellonian Univ, Dept Endocrinol, Coll Med, Nucl Med Unit, Krakow, Poland
[2] Jagiellonian Univ, Dept Hematol, Coll Med, Krakow, Poland
[3] Jagiellonian Univ, Chair Hematol, Coll Med, Krakow, Poland
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2006年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S195 / S195
页数：1
相关论文
共 50 条
  • [1] 90Y-ibritumomab tiuxetan (90Y-Zevalin) radioimmunotherapy as a consolidation strategy in mantle cell lymphoma (MCL) patients
    Jurczak, W.
    Giza, A.
    Hubalewska-Dydejczyk, A.
    Sowa-Staszczak, A.
    Glowa, B.
    Szostek, M.
    Krochmalczyk, D.
    Wegrzyn, J.
    Knopinska-Posluszny, W.
    Zdziarska, B.
    Kyrcz-Krzemien, S.
    Poplawska, L.
    Walewski, J.
    Wrobel, T.
    Skotnicki, A. B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S168 - S168
  • [2] Consolidation of chemotherapy response in mantle cell lymphoma (MCL) patients with 90Y-ibritumomab tiuxetan (90Y-Zevalin) radioimmunotherapy (RIT).
    Jurczak, W
    Giza, A
    Krochmalczyk, D
    Wegrzyn, J
    Hubalewska-Dydejczyk, A
    Sowa-Staszczak, A
    Knopinska-Posluszny, W
    Zdziarska, B
    Kyrcz-Krzemien, S
    Boguradzki, P
    Poplawska, L
    Skotnicki, A
    BLOOD, 2005, 106 (11) : 690A - 690A
  • [3] 90Y-Zevalin® (90Y-Ibritumomab tiuxetan) radioimmunotherapy (RIT) consolidation in mantle cell lymphoma (MCL) patients, not illegible for intensive therapy protocols
    Jurczak, Wojciech
    Giza, Agnieszka
    Zimowska-Curylo, Dagmara
    Hubalewska-Dydejczyk, Alicja
    Sowa-Staszczak, Anna
    Knopinska-Posluszny, Wanda
    Hellmann, Andrzej
    Zdziarska, Barbara
    Wrobel, Tomasz
    Krycz-Krzemien, Slawomira
    Poplawska, Lidia
    Walewski, Jan
    Skotnicki, Aleksander B.
    BLOOD, 2007, 110 (11) : 196B - 196B
  • [4] Radioimmunotherapy with 90Y-Zevalin (90y-Ibritumomab Tiuxetan) in Patients with Non Hodgkin Lymphoma: Preliminary Experience of our Centre
    Vallejos, V.
    Calvo, E.
    Xicoy, B.
    Riba, J.
    Rubio, A.
    Sola, M.
    Mila, M.
    Rosado, M.
    Ribera, J. M.
    Fraile, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S352 - S353
  • [5] 90Y-Zevalin® (90Y-ibritumomab tiuxetan) radioimmunotherapy (RIT) consolidation of FCM induction chemotherapy in mantle cell lymphoma (MCL) patients:: Results from the PLRG upon completed enrollment.
    Jurczak, Wojciech
    Giza, A.
    Szostek, M.
    Hubalewska-Dydejczyk, A.
    Sowa-Staszczak, A.
    Knopinska-Posluszny, W.
    Hellmann, A.
    Zdziarska, B.
    Wrobel, T.
    Krycz-Krzemien, S.
    Poplawska, L.
    Federowicz, I.
    Walewski, Jan
    Skotnicki, Aleksander
    BLOOD, 2006, 108 (11) : 777A - 777A
  • [6] A phase 1 trial of 90Y-Zevalin radioimmunotherapy with autologous stem cell transplant for multiple myeloma
    Dispenzieri, A.
    D'Souza, A.
    Gertz, M. A.
    Laumann, K.
    Wiseman, G.
    Lacy, M. Q.
    LaPlant, B.
    Buadi, F.
    Hayman, S. R.
    Kumar, S. K.
    Dingli, D.
    Hogan, W. J.
    Ansell, S. M.
    Gastineau, D. A.
    Inwards, D. J.
    Micallef, I. N.
    Porrata, L. F.
    Johnston, P. B.
    Litzow, M. R.
    Witzig, T. E.
    BONE MARROW TRANSPLANTATION, 2017, 52 (10) : 1372 - 1377
  • [7] A phase 1 trial of 90Y-Zevalin radioimmunotherapy with autologous stem cell transplant for multiple myeloma
    A Dispenzieri
    A D'Souza
    M A Gertz
    K Laumann
    G Wiseman
    M Q Lacy
    B LaPlant
    F Buadi
    S R Hayman
    S K Kumar
    D Dingli
    W J Hogan
    S M Ansell
    D A Gastineau
    D J Inwards
    I N Micallef
    L F Porrata
    P B Johnston
    M R Litzow
    T E Witzig
    Bone Marrow Transplantation, 2017, 52 : 1372 - 1377
  • [8] Manageable and transient hematologic toxicity associated with 90Y-ibritumomab tiuxetan (90Y-Zevalin) consolidation of FCM chemotherapy in mantle cell lymphoma (MCL) patients
    Jurczak, W
    Szostek, M
    Giza, A
    Rudzki, Z
    Skotnicki, A
    Hugh-Jones, C
    BLOOD, 2005, 106 (11) : 278B - 279B
  • [9] Limoges' Hospital Experience of 90Y-ZEVALIN® in NonHodgkin's Lymphoma Treatment
    Gruliere, A.
    Abraham, J.
    Dalmay, F.
    Monteil, J.
    Bordessoule, D.
    Quelven, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S397 - S397
  • [10] Radioimmunotherapy with anti-CD antibodies in patients with NHL our experience with 90Y-Zevalin in northern Greece.
    Iakovou, I.
    Badiavas, K.
    Chatzopoulos, D.
    Papachristou, M.
    Karatzas, N.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S326 - S326
12345